PPARGC1A and cardiac hypertrophy: In triiodothyronine (T3) induced cardiac hypertrophy, the mRNA level of PGC-1α decreases first and subsequently increases, but the overexpression of PGC-1α improves cardiac function through increasing energy production and mitochondrial biogenesis.